On the fly News and insights, exclusive to thefly.com

MRNA

Moderna

$128.00 /

+18.82 (+17.24%)

07:07
11/30/20
11/30
07:07
11/30/20
07:07

Moderna will submit for Emergency Use Authorization with FDA

Moderna announced that it will submit for an Emergency Use Authorization with the U.S. FDA and an application for Conditional Marketing Authorization with the European Medicines Agency for its Covid-19 vaccine mRNA-1273. The company has already initiated the rolling review process with the EMA, Health Canada, SwissMedic, the United Kingdom Medicines and Healthcare products Regulatory Agency, Ministry of Health in Israel, and Health Sciences Authority in Singapore and intends to seek Prequalification and/or Emergency Use Listing with the World Health Organization. Additionally, Moderna announced that the FDA's Vaccines and Related Biological Products Advisory Committee meeting to review the safety and efficacy data package for mRNA-1273 will likely be scheduled for Thursday, December 17. The company expects that the U.S. Centers for Disease Control and Prevention Advisory Committee on Immunization Practices will make a recommendation on immunization priorities. Moderna anticipates that the shipping of mRNA-1273 to designated distribution points throughout the U.S. will occur shortly after an Emergency Use Authorization is granted. Shares of Moderna are up 10%, or $13.19, to $140.22 in premarket trading.

  • 12

    Feb

  • 19

    May

MRNA Moderna
$128.00 /

+18.82 (+17.24%)

11/27/20 Argus
AstraZeneca's COVID vaccine faces high bar for FDA authorization, says Argus
11/25/20 Goldman Sachs
Moderna price target raised to $139 from $107 at Goldman Sachs
11/23/20
Fly Intel: Top five analyst initiations
11/23/20 Wells Fargo
Moderna initiated with an Equal Weight at Wells Fargo

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.